Weill Cornell Medicine researcher Nancy Du received a $500,000 grant from the Congressionally Directed Medical Research Programs at the U.S. Department of Defense, but a stop-work order brought her research to a halt in April.
Cornell researchers have identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes typhoid fever.
Cornell Tech researchers unveiled a robot that helps emergency room teams locate life-saving supplies faster, revealing how design can shape collaboration under pressure.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center provide fresh insights about how cancers evolve when they metastasize – insights that could aid in developing strategies to improve the effectiveness of treatment.
Cornell researchers have discovered a new cell signaling pathway involved in ovulation, a potential target for future research on infertility, contraception and ovarian disease.
A clinical trial in patients with advanced breast cancer has found the use of liquid biopsy blood tests for early detection of a treatment-resistant mutation, followed by a new type of treatment, substantially extends the period of tumor control.
Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports the way we think and act.
